Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.

Q4 2024 Earnings Call Transcript January 31, 2025 AbbVie Inc. misses on earnings expectations. Reported EPS is $2.16 EPS, ...

Experts tell Sky News that although the UK's water treatment system is unable to get rid of tiny traces of "forever chemicals" that have been linked to cancers and other long-term health conditions, ...

AbbVie Inc.'s stock rose 4% early Friday, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth needed to ...

Resisting the reality of chronic illness can lead to emotional distress. Acceptance, on the other hand, can open the door to proactive coping.

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

New legislation signed into law by Governor Kathy Hochul is positioning New York as a leader in Parkinson’s Disease research. The new bill establ ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

Inhibikase’s setback continues biopharma’s losing streak against Parkinson’s, marked by several clinical failures and ...

Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...

So I really depend on my medication." Sir Peter Luff, a former defence minister and MP for Mid Worcestershire, explained how ...

Alterity plans to seek US FDA fast-track approval after posting positive phase II results for multiple system atrophy ...